Back to List View Graph View

Insulin like growth factor binding protein 3

Insulin-like growth factor-binding protein 3 (IGFBP-3) is a protein of the insulin-like growth factor 1 (IGF-1) axis that participates in neurotrophic and metabolic processes.

Where the papers sit

8 papers from the last 6 months study insulin like growth factor binding protein 3 directly · updated from PubMed 12 Nov 2026

Study type 0 clinical trials · 2 observational · 2 human data · 3 preclinical · 1 unclassified

Themes no clear themes

Those 8 do not share a common subject.

  • IGF-axis binding proteins recur as biomarkers or candidate targets across inflammatory, neurodegenerative, renal, metabolic, developmental, dental, and cancer studies. The work links them to disease severity, symptom trajectories, tissue dysfunction, cellular senescence, and prognosis. It spans observational cohorts, multi-omics analyses, and mechanistic interventions rather than testing one shared biological question. No consistent therapeutic direction or common mechanism emerges from this heterogeneous set.

    8 papers

Papers

The 8 papers from the last 6 months that study insulin like growth factor binding protein 3 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

No clear themes (8)
  1. IGFBP7-targeting monoclonal antibodies attenuate the endothelial inflammatory niche in psoriasis-like inflammation. Autoimmunity · 6 Nov 2026 PMID 42992544
  2. Association between IGFBP-3 and longitudinal neuropsychiatric symptom trajectories in early Parkinson's disease: a longitudinal cohort study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 18 Oct 2026 PMID 42891731
  3. Multi-omics analyses based identification of therapeutic targets for rapid kidney function decline and chronic kidney disease, a mendelian randomization study. International urology and nephrology · 12 Oct 2026 PMID 42862516
  4. IGFBP5 alleviates periodontitis by reversing human dental follicle stem cell senescence via the non-canonical Wnt pathway. International journal of oral science · 14 Sept 2026 PMID 42736271
  5. Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome. Neurology · 1 Sept 2026 PMID 42679336
  6. Growth parameters and IGF-1 axis biomarkers differ among omnivorous, vegetarian, and vegan children. European journal of nutrition · 29 Aug 2026 PMID 42667434
  7. SGLT2 inhibition attenuates cytoskeletal and proteostatic dysfunction through the AGE-RAGE-IGFBP2-FBN1 signaling axis in diabetic lenses. European journal of pharmacology · 14 Aug 2026 PMID 42601001
  8. IGFBP3 and UBE2C are associated with protein modification pathways and serve as prognostic markers in glioma. Brain research · 3 Jul 2026 PMID 42398694

By study type

Observational studies and case reports (2)
  1. Association between IGFBP-3 and longitudinal neuropsychiatric symptom trajectories in early Parkinson's disease: a longitudinal cohort study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 18 Oct 2026 PMID 42891731
  2. Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome. Neurology · 1 Sept 2026 PMID 42679336
Human data, design not indexed (2)
  1. Growth parameters and IGF-1 axis biomarkers differ among omnivorous, vegetarian, and vegan children. European journal of nutrition · 29 Aug 2026 PMID 42667434
  2. IGFBP3 and UBE2C are associated with protein modification pathways and serve as prognostic markers in glioma. Brain research · 3 Jul 2026 PMID 42398694
Preclinical: animal, cell and lab studies (3)
  1. IGFBP7-targeting monoclonal antibodies attenuate the endothelial inflammatory niche in psoriasis-like inflammation. Autoimmunity · 6 Nov 2026 PMID 42992544
  2. IGFBP5 alleviates periodontitis by reversing human dental follicle stem cell senescence via the non-canonical Wnt pathway. International journal of oral science · 14 Sept 2026 PMID 42736271
  3. SGLT2 inhibition attenuates cytoskeletal and proteostatic dysfunction through the AGE-RAGE-IGFBP2-FBN1 signaling axis in diabetic lenses. European journal of pharmacology · 14 Aug 2026 PMID 42601001
Unclassified: not yet indexed with MeSH (1)
  1. Multi-omics analyses based identification of therapeutic targets for rapid kidney function decline and chronic kidney disease, a mendelian randomization study. International urology and nephrology · 12 Oct 2026 PMID 42862516